Tersera Therapeutics Overview
- Year Founded
-
2016
- Status
-
Private
- Employees
-
168
- Latest Deal Type
-
Div. Recap.
- Financing Rounds
-
12
- Investments
-
7
Tersera Therapeutics General Information
Description
Manufacturer of specialty pharmaceutical products intended to provide improved outcomes for patients. The company specializes in acquiring, developing and marketing specialty pharmaceutical products with a focus on select therapeutic areas.
Contact Information
Website
www.tersera.comCorporate Office
- 520 Lake Cook Road
- Suite 500
- Deerfield, IL 60015
- United States
Corporate Office
- 520 Lake Cook Road
- Suite 500
- Deerfield, IL 60015
- United States
Tersera Therapeutics Timeline
Tersera Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Tersera Therapeutics Comparisons
Industry
Financing
Details
Tersera Therapeutics Competitors (2)
One of Tersera Therapeutics’s 2 competitors is Novartis, a Corporation company based in Basel, Switzerland.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Novartis | Corporation | Basel, Switzerland | ||||
| Pfizer (Vienna) | Corporation | Vienna, Austria |
Tersera Therapeutics Patents
Tersera Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20260014149-A1 | Methods of treating merkel cell carcinoma with tryptophan hydoxylase inhibitors | Pending | 15-Jul-2024 | ||
| WO-2026019787-A1 | Methods of treating merkel cell carcinoma with tryptophan hydroxylase inhibitors | Pending | 15-Jul-2024 | ||
| US-20250367252-A1 | Goserelin implant dosing regimens for improved patient compliance | Pending | 04-Jun-2024 | ||
| US-20250367261-A1 | Goserelin implant dosing regimens for improved patient compliance | Pending | 04-Jun-2024 | ||
| US-12653826-B2 | Methods of reducing the likelihood of carcinoid heart disease in patients with neuroendocrine tumors | Active | 01-Apr-2022 | A61K31/506 |
Tersera Therapeutics Signals
Tersera Therapeutics Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Tersera Therapeutics Investments (7)
Tersera Therapeutics’s most recent deal was a Buyout/LBO with Margenza for . The deal was made on 12-Nov-2024.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Margenza | 12-Nov-2024 | Buyout/LBO | Buildings and Property | ||
| Xermelo | 08-Sep-2020 | Buyout/LBO | Buildings and Property | ||
| Prialt | 27-Sep-2018 | Buyout/LBO | Pharmaceuticals | ||
| Tesaro (North American rights of VARUBI) | 12-Jul-2018 | Buyout/LBO | Buildings and Property | ||
| AstraZeneca (Zoladex commercial rights) | 31-Mar-2017 | Buyout/LBO | Distributors (Healthcare) |
Tersera Therapeutics Exits (1)
Tersera Therapeutics’s most recent exit was on 27-Sep-2018 from Prialt. The exit was categorized as with 2 buyers.
| Company Name | Exit Date | Exit Type | Exit Size | Status | Buyers |
|---|---|---|---|---|---|
| Prialt | 27-Sep-2018 | Completed |
|
Tersera Therapeutics Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Xermelo | TX |
Tersera Therapeutics FAQs
-
When was Tersera Therapeutics founded?
Tersera Therapeutics was founded in 2016.
-
Where is Tersera Therapeutics headquartered?
Tersera Therapeutics is headquartered in Deerfield, IL.
-
What is the size of Tersera Therapeutics?
Tersera Therapeutics has 168 total employees.
-
What industry is Tersera Therapeutics in?
Tersera Therapeutics’s primary industry is Pharmaceuticals.
-
Is Tersera Therapeutics a private or public company?
Tersera Therapeutics is a Private company.
-
What is Tersera Therapeutics’s current revenue?
The current revenue for Tersera Therapeutics is .
-
How much funding has Tersera Therapeutics raised over time?
Tersera Therapeutics has raised $326M.
-
Who are Tersera Therapeutics’s investors?
Oaktree Capital Management and GTCR have invested in Tersera Therapeutics.
-
Who are Tersera Therapeutics’s competitors?
Novartis and Pfizer (Vienna) are competitors of Tersera Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process